603392: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

CHN:603392

SummaryFactSheetFinancial
Price
CN¥34.66
Loss Chance
57.9%
1.72JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Biotechnology
39 / 82
Health Care
269 / 486
China
?
2,619 / 5,261
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Beijing Strong Biotechnologies
CHN:300406
5.62
CN¥11.75
133.98%
Amoy Diagnostics Co., Ltd.
CHN:300685
7.60
CN¥20.41
7.61%
Acrobiosystems Co.,Ltd.
CHN:301080
5.79
CN¥40.55
143.02%
Acrobiosystems Co.,Ltd.
CHN:301080
5.79
CN¥40.55
143.02%
Gan & Lee Pharmaceuticals.
CHN:603087
5.89
CN¥52.28
13.92%
Jitta Factors
Growth Opportunity (17)
Recent Business Performance (19)
Financial Strength (57)
Return to Shareholders (33)
Competitive Advantage (28)
Jitta Signs
Debt LevelLow Long Term Debt
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 352.72% in the last year
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
1.72
100.00%
3.57
834.96%
4.23
> 1,000%
Biotechnology
5.62
133.98%
7.60
7.61%
5.79
143.02%
COMPANY DESCRIPTION
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests for detection of Hepatitis virus infections; P-85 Ab for nasopharyngeal cancer screening; and TB-IGRA for large population screening. It also provides diagnostic assays, such as high-value Hepatitis B core antibody tests, Hepatitis E Urine tests, Hepatitis D virus detection, IL-6, HIV 4th generation CLIA, Helicobacter pylori antibody, gastrin-17, and soluble transferrin receptor assays; and enzyme-linked immunosorbent assay (ELISA), colloidal gold, molecular, clinical laboratory quality control products, and bioactive materials for various infectious diseases, such as HIV, Hepatitis, Tuberculosis, and Influenza A/B. In addition, the company offers core diagnostic solutions comprising chronic disease management, integrated Hepatitis E screening and prevention, full lifecycle women's health programs, and intelligent laboratory services. Further, it provides medical instruments, diagnostic tests, quality control products, bioactive materials, and diagnostics solutions; and HPV, Hepatitis E, and Nasal Spray COVID-19 vaccines. The company was founded in 1991 and is headquartered in Beijing, China. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a subsidiary of Yangshengtang Co., Ltd.
www.ystwt.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.